https://clinicaltrials.gov/study/NCT06255990?term=skin%20substitute&rank=6
A 42-patient CT will investigate a novel dermal substitute, NovoSorb BTM, for the treatment of full-thickness skin defects versus SoC with primary outcome of skin elasticity at 1 year post-transplantation vs normal skin. Recruitment is ongoing with estimated study completion in June 2027. clinicaltrials.gov
https://clinicaltrials.gov/study/NCT06255990?term=skin%20substitu...
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.09 |
Change
-0.005(0.24%) |
Mkt cap ! $1.442B | |||
| Open | High | Low | Value | Volume |
| $2.10 | $2.14 | $2.08 | $378.1K | 179.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 21223 | $2.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.09 | 3806 | 9 |
View Market Depth
| Last trade - 11.06am 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.08 |
Change
-0.005 ( 0.37 %) |
||||
| Open | High | Low | Volume | ||
| $2.11 | $2.14 | $2.08 | 35397 | ||
| Last updated 11.27am 06/05/2024 ? | |||||
| PNV (ASX) Chart |